Datamonitor releases a new report – “Biosimilars: Regulatory Update”

May 11, 2012 6:43 AM

Datamonitor is an international company providing market intelligence, data analysis and opinion via a worldwide network of in-house analysts. Datamonitor is a division of Informa plc, a United Kingdom-based publisher and conference company.

The company has released a new report, “Biosimilars: Regulatory Update” this month.

After consultation with industry, the US FDA published draft biosimilars guidelines in February 2012 and although details are lacking in a number of areas such as interchangeability, the guidance sets out the agency’s broad views and gives developers greater certainty for the initiation of development programs.

In this report, Datamonitor analyses the US guidance, new interferon beta biosimilar guidelines in EU and also worldwide developments such as the situation in Iran.

If you want to buy the report, you can check the table of contents and rates from here:


Source: Wikipedia, Reportsnreports

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?


Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!